Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Cash from Operating Activities
Interpace Biosciences Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Cash from Operating Activities
$2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$13.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Interpace Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
2.4m
USD
Based on the financial report for Sep 30, 2023, Interpace Biosciences Inc's Cash from Operating Activities amounts to 2.4m USD.